PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
2.78M / 3.59M (Avg.)
-1.55 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-0.61
Negative P/E while CRN.AX shows 0.00. Joel Greenblatt would examine path to profitability versus competitor.
No Data
No Data available this quarter, please select a different quarter.
-1.77
Negative equity while CRN.AX shows P/B of 0.00. Joel Greenblatt would examine balance sheet repair potential.
-6.42
Negative FCF while CRN.AX shows P/FCF of 0.00. Joel Greenblatt would examine cash flow improvement potential.
-7.16
Negative operating cash flow while CRN.AX shows P/OCF of 0.00. Joel Greenblatt would examine operational improvement potential.
-1.77
Negative fair value while CRN.AX shows ratio of 0.00. Joel Greenblatt would examine valuation model differences.
-40.71%
Earnings yield 7-10% - Fair value range. Seth Klarman would verify if yield provides sufficient margin of safety. Check Operating Margins.
-15.57%
Negative FCF while CRN.AX shows yield of 0.00%. Joel Greenblatt would examine cash flow improvement potential.